304 related articles for article (PubMed ID: 29352113)
1. Polo-like kinase 4 mediates epithelial-mesenchymal transition in neuroblastoma via PI3K/Akt signaling pathway.
Tian X; Zhou D; Chen L; Tian Y; Zhong B; Cao Y; Dong Q; Zhou M; Yan J; Wang Y; Qiu Y; Zhang L; Li Z; Wang H; Wang D; Ying G; Zhao Q
Cell Death Dis; 2018 Jan; 9(2):54. PubMed ID: 29352113
[TBL] [Abstract][Full Text] [Related]
2. ISL1 promoted tumorigenesis and EMT via Aurora kinase A-induced activation of PI3K/AKT signaling pathway in neuroblastoma.
Li M; Sun C; Bu X; Que Y; Zhang L; Zhang Y; Zhang L; Lu S; Huang J; Zhu J; Wang J; Sun F; Zhang Y
Cell Death Dis; 2021 Jun; 12(6):620. PubMed ID: 34131100
[TBL] [Abstract][Full Text] [Related]
3. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
[TBL] [Abstract][Full Text] [Related]
4. Dehydroeffusol inhibits viability and epithelial-mesenchymal transition through the Hedgehog and Akt/mTOR signaling pathways in neuroblastoma cells.
He K; Duan G; Li Y
Eur J Pharmacol; 2018 Jun; 829():93-101. PubMed ID: 29665365
[TBL] [Abstract][Full Text] [Related]
5.
Jin Q; Chen Y; Du S; Xu D; Yue J; Cai L; Yuan X
Curr Cancer Drug Targets; 2022; 22(11):919-930. PubMed ID: 35909289
[TBL] [Abstract][Full Text] [Related]
6. Fraxetin down-regulates polo-like kinase 4 (PLK4) to inhibit proliferation, migration and invasion of prostate cancer cells through the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathway.
Ma Z; Sun Y; Peng W
Bioengineered; 2022 Apr; 13(4):9345-9356. PubMed ID: 35387563
[TBL] [Abstract][Full Text] [Related]
7. Polo-Like Kinase 4 (PLK4) Is Overexpressed in Central Nervous System Neuroblastoma (CNS-NB).
Bailey AW; Suri A; Chou PM; Pundy T; Gadd S; Raimondi SL; Tomita T; Sredni ST
Bioengineering (Basel); 2018 Nov; 5(4):. PubMed ID: 30400339
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of MEG3 promotes neuroblastoma development through FOXO1-mediated autophagy and mTOR-mediated epithelial-mesenchymal transition.
Ye M; Lu H; Tang W; Jing T; Chen S; Wei M; Zhang J; Wang J; Ma J; Ma D; Dong K
Int J Biol Sci; 2020; 16(15):3050-3061. PubMed ID: 33061817
[TBL] [Abstract][Full Text] [Related]
9. PI3K Inhibitor Combined With Chemotherapy Can Enhance the Apoptosis of Neuroblastoma Cells In Vitro and In Vivo.
Geng X; Xie L; Xing H
Technol Cancer Res Treat; 2016 Oct; 15(5):716-22. PubMed ID: 26224681
[TBL] [Abstract][Full Text] [Related]
10. PEST-containing nuclear protein mediates the proliferation, migration, and invasion of human neuroblastoma cells through MAPK and PI3K/AKT/mTOR signaling pathways.
Wu DD; Gao YR; Li T; Wang DY; Lu D; Liu SY; Hong Y; Ning HB; Liu JP; Shang J; Shi JF; Wei JS; Ji XY
BMC Cancer; 2018 May; 18(1):499. PubMed ID: 29716528
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-203 inhibits the malignant progression of neuroblastoma by targeting Sam68.
Zhao D; Tian Y; Li P; Wang L; Xiao A; Zhang M; Shi T
Mol Med Rep; 2015 Oct; 12(4):5554-60. PubMed ID: 26136151
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K
Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154
[TBL] [Abstract][Full Text] [Related]
14. Genetic and pharmacologic identification of Akt as a mediator of brain-derived neurotrophic factor/TrkB rescue of neuroblastoma cells from chemotherapy-induced cell death.
Li Z; Jaboin J; Dennis PA; Thiele CJ
Cancer Res; 2005 Mar; 65(6):2070-5. PubMed ID: 15781614
[TBL] [Abstract][Full Text] [Related]
15. NLRP3 in human glioma is correlated with increased WHO grade, and regulates cellular proliferation, apoptosis and metastasis via epithelial-mesenchymal transition and the PTEN/AKT signaling pathway.
Yin XF; Zhang Q; Chen ZY; Wang HF; Li X; Wang HX; Li HX; Kang CM; Chu S; Li KF; Li Y; Qiu YR
Int J Oncol; 2018 Sep; 53(3):973-986. PubMed ID: 30015880
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of Polo-like kinase 4 induces cell apoptosis and G2/M arrest in acute myeloid leukemia.
Chen S; Zhong L; Chu X; Wan P; Liu Z; Lu Y; Zhang Z; Wang X; Zhou Z; Shao X; Liu B
Pathol Res Pract; 2023 Mar; 243():154376. PubMed ID: 36821942
[TBL] [Abstract][Full Text] [Related]
17. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
18. Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling.
Bieerkehazhi S; Chen Z; Zhao Y; Yu Y; Zhang H; Vasudevan SA; Woodfield SE; Tao L; Yi JS; Muscal JA; Pang JC; Guan S; Zhang H; Nuchtern JG; Li H; Li H; Yang J
Oncotarget; 2017 Jan; 8(1):1469-1480. PubMed ID: 27903968
[TBL] [Abstract][Full Text] [Related]
19. Polo-like kinase 4 (Plk4) potentiates anoikis-resistance of p53KO mammary epithelial cells by inducing a hybrid EMT phenotype.
Fonseca I; Horta C; Ribeiro AS; Sousa B; Marteil G; Bettencourt-Dias M; Paredes J
Cell Death Dis; 2023 Feb; 14(2):133. PubMed ID: 36797240
[TBL] [Abstract][Full Text] [Related]
20. Role of Polo-Like Kinase 4 (PLK4) in Epithelial Cancers and Recent Progress in its Small Molecule Targeting for Cancer Management.
Garvey DR; Chhabra G; Ndiaye MA; Ahmad N
Mol Cancer Ther; 2021 Apr; 20(4):632-640. PubMed ID: 33402398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]